6202
Y. Qian et al. / Tetrahedron 68 (2012) 6198e6203
silica gel 60 (200e300mesh) with freshly distilled solvents. Melting
points are uncorrected. 1H and 13C NMR (TMS used as internal
standard) spectra were recorded with a Bruker ARX300 spec-
trometer. High resolution mass spectra for all the new compounds
were done by Micro mass Q-Tof instrument (ESI). The crystal
structure was recorded on a X-ray diffraction spectrometer.
117.05, 114.21, 63.80. HRMS (ESI/[MþNa]þ) Calcd. For:
C16H9Cl2FN2O4Na 404.9821, found 404.9836.
4.2.8. 3h. White solid. Mp 134e136 ꢁC. 1H NMR (300 MHz, CDCl3):
d
7.85e7.95 (m, 2H), 7.75e7.84 (m, 2H), 7.67 (d, J¼8.7 Hz, 2H), 7.50
(d, J¼8.4 Hz, 2H), 6.61 (s, 1H). 13C NMR (75 MHz, CDCl3)
d 166.60,
134.93, 132.44, 131.96, 131.00, 129.89, 124.64, 124.14, 114.21, 63.89.
HRMS (ESI/[MþNa]þ) Calcd. For: C16H9BrCl2N2O4Na 464.9020,
found 464.9003.
4.2. General procedure for aminohalogenation
Into a dry reaction tube were added the 2 (0.5 mmol), N-
chlorophtahlimide (1.5 mmol), NaOH (1.5 mmol), and they were
mixed with freshly distilled CH2Cl2 (3.0 mL) under nitrogen at-
mosphere. The mixture was stirred at room temperature for 48 h.
The reaction was then quenched by saturated aqueous Na2SO3
(2.0 mL) solution. The solid precipitates were filtered off and the
filtrate was extracted with CH2Cl2 three times. Then the combined
organic phase was washed with brine and dried with anhydrous
Na2SO4. After being concentrated, the mixture was purified via
column chromatography with ethyl acetate and petroleum ether
(v/v¼1:4) as eluent to give the product.
4.2.9. 3i. White solid. Mp 100e103 ꢁC. 1H NMR (300 MHz, CDCl3):
d
7.85e8.00 (m, 3H), 7.74e7.84 (m, 3H), 7.48e7.60 (m, 1H),
7.22e7.32 (m, 1H), 6.60 (s, 1H). 13C NMR (75 MHz, CDCl3)
d
166.55,
134.98, 133.69, 133.23, 132.95, 130.97, 130.20, 129.37, 124.18, 122.61,
114.13, 63.72. HRMS (ESI/[MþNa]þ) Calcd. For: C16H9BrCl2N2O4Na
464.9020, found 464.9031.
4.2.10. 3j. White solid. Mp 130e132 ꢁC. 1H NMR (300 MHz, CDCl3):
d
7.85e7.95 (m, 2H), 7.71e7.81 (m, 4H), 6.87 (d, J¼8.7 Hz, 2H), 6.61 (s,
1H), 3.80 (s, 3H). 13C NMR (75 MHz, CDCl3)
d
166.79, 160.71, 134.77,
132.47,131.14,124.00,122.67,114.93,113.98, 64.25, 55.30. HRMS (ESI/
4.2.1. 3a. White solid. Mp 124e126 ꢁC. 1H NMR (300 MHz, CDCl3):
[MþNa]þ) Calcd. For: C17H12Cl2N2O5Na 417.0021, found 417.0015.
d
7.85e7.95 (m, 2H), 7.70e7.84 (m, 4H), 7.32e7.45 (m, 3H), 6.67 (s,
1H). 13C NMR (75 MHz, CDCl3)
d
166.68, 134.82, 131.09, 131.01,
4.2.11. 3k. White solid. Mp 112e114 ꢁC. 1H NMR (300 MHz, CDCl3):
130.73, 130.03, 128.74, 124.05, 114.66, 64.52. HRMS (ESI/[MþNa]þ)
d
7.97 (d, J¼2.1 Hz, 1H), 7.86e7.94 (m, 2H), 7.75e7.84 (m, 3H),
Calcd. For: C16H10Cl2N2O4Na 386.9915, found 386.9910.
6.86e6.92 (d, J¼8.7 Hz, 1H), 6.55 (s, 1H), 3.90 (s, 3H). 13C NMR
(75 MHz, CDCl3)
d 166.66, 157.10, 135.86, 134.91, 131.49, 131.01,
4.2.2. 3b. White solid. Mp 131e132 ꢁC. 1H NMR (300 MHz, CDCl3):
124.11, 123.94, 114.52, 111.62, 111.44, 63.53, 56.32. HRMS (ESI/
d
8.32e8.42(m,1H), 7.73e7.91 (m, 4H), 7.30e7.44 (m, 3H), 7.03 (s,1H).
[MþNa]þ) Calcd. For: C17H11BrCl2N2O5Na 494.9126, found 494.9137.
13C NMR (75 MHz, CDCl3)
d
166.27, 134.86, 134.68, 131.64, 130.99,
130.95, 130.11, 128.58, 126.50, 124.04, 114.39, 59.98. HRMS (ESI/
4.2.12. 3l. White solid. Mp 129e131 ꢁC. 1H NMR (300 MHz, CDCl3):
[MþNa]þ) Calcd. For: C16H9Cl3N2O4Na 420.9526, found 420.9520.
d
7.87e7.98 (m, 3H), 7.75e7.85 (m, 2H), 7.60e7.71 (m, 1H),
7.37e7.50 (m, 1H), 6.58 (s, 1H). 13C NMR (75 MHz, CDCl3)
d
166.50,
4.2.3. 3c. White solid. Mp 116e117 ꢁC. 1H NMR (300 MHz, CDCl3):
135.04, 134.84, 132.79, 130.91, 130.81, 130.63, 130.07, 128.33, 124.24,
113.90, 63.29. HRMS (ESI/[MþNa]þ) Calcd. For: C16H8Cl4N2O4Na
456.9106, found 456.9103.
d
8.84e8.95 (m, 2H), 7.72e7.83 (m, 2H), 7.65e7.72 (m, 2H),
7.15e7.23 (m, 2H), 6.63 (s, 1H), 2.34 (s, 3H). 13C NMR (75 MHz,
CDCl3) d 166.74, 140.19, 134.78, 131.14, 130.68, 129.42, 127.91, 124.01,
114.75, 64.37, 21.24. HRMS (ESI/[MþNa]þ) Calcd. For:
4.2.13. 3m. White solid. Mp 186e188 ꢁC. 1H NMR (300 MHz, CDCl3):
C17H12Cl2N2O4Na 401.0072, found 401.0066.
d
8.55e8.65 (m, 1H), 8.00 (d, J¼8.4 Hz, 1H), 7.80e7.96 (m, 4H),
7.70e7.78 (m, 2H), 7.45e7.61 (m, 4H). 13C NMR (75 MHz, CDCl3)
166.72,134.77, 133.90, 131.39,130.99,130.79,129.58,128.90,127.84,
4.2.4. 3d. White solid. Mp 131e133 ꢁC. 1H NMR (300 MHz, CDCl3):
d
d
8.15e8.23 (m,1H), 7.69e7.83 (m, 4H), 7.21e7.38 (m, 6H), 7.15 (s,
126.03, 125.75, 124.61, 124.02, 121.61, 115.01, 58.76. HRMS (ESI/
1H), 7.00e7.08 (m,1H), 6.91 (d, J¼8.4 Hz,1H), 4.97e5.10 (m, 2H). 13C
[MþNa]þ) Calcd. For: C20H12Cl2N2O4Na 437.0072, found 437.0066.
NMR (75 MHz, CDCl3)
d 166.59, 156.06, 135.90, 134.44, 131.23,
130.82, 130.64, 128.53, 128.06, 127.50, 123.83, 120.43, 119.64, 114.81,
112.19, 70.57, 57.14. HRMS (ESI/[MþNa]þ) Calcd. For:
C23H16Cl2N2O5Na 493.0334, found 493.0328.
4.2.14. 3n. White solid. Mp 171e173 ꢁC. 1H NMR (300 MHz, CDCl3):
d
8.24 (s, 1H), 7.73e7.97 (m, 8H), 7.48e7.58 (m, 2H), 6.99 (s, 1H). 13
C
NMR (75 MHz, CDCl3) d 166.78, 134.82, 133.60, 132.77, 131.11, 131.03,
128.60, 128.49, 128.37, 127.62, 127.47, 127.16, 126.73, 124.07, 114.67,
64.66. HRMS (ESI/[MþNa]þ) Calcd. For: C20H12Cl2N2O4Na 437.0072,
found 437.0081.
4.2.5. 3e. White solid. Mp 112e115 ꢁC. 1H NMR (300 MHz, CDCl3):
d
7.85e7.95 (m, 2H), 7.70e7.85 (m, 4H), 7.30e7.40 (m, 2H), 6.62 (s,
1H). 13C NMR (75 MHz, CDCl3)
d 166.62, 136.30, 134.93, 132.23,
131.01, 129.36, 128.98, 124.14, 114.30, 63.83. HRMS (ESI/[MþNa]þ)
4.2.15. 3o. White solid. Mp 41e43 ꢁC. 1H NMR (300 MHz, CDCl3):
Calcd. For: C16H14Cl2N2O4Na 420.9526, found 420.9532.
d
7.87e7.98 (m, 4H), 7.75e7.85 (m, 2H), 7.62e7.70 (m, 2H), 6.70 (s,
1H).13C NMR (75 MHz, CDCl3)
d
166.54,135.00,134.80,131.19,130.95,
4.2.6. 3f. White solid. Mp 133e135 ꢁC. 1H NMR (300 MHz, CDCl3):
129.42, 125.69, 125.64, 124.19, 113.97, 63.81, 29.71. HRMS (ESI/
d
7.87e7.95 (m, 2H), 7.75e7.85 (m, 4H), 7.00e7.12 (m, 2H), 6.64 (s,
[MþNa]þ) Calcd. For: C17H9Cl2F3N2O4Na 454.9789, found 454.9780.
1H). 13C NMR (75 MHz, CDCl3)
d
166.68, 165.13, 161.82, 134.89,
133.14, 133.02, 131.03, 126.78, 124.10, 115.93,115.64, 114.53, 63.86.
HRMS (ESI/[MþNa]þ) Calcd. For: C16H9Cl2FN2O4Na 404.9821, found
404.9823.
4.3. General procedure for reduction reaction of 3a catalyzed
by Pd/C
Into a dry reaction vial were added 3a (0.5 mmol), 10% Pd/C
(10 mg) and CH3OH (25 mL). The mixture was stirred at room
temperature under hydrogen for the desired reaction time then
passed through Celite. The Celite was washed with ether and the
organic phase was combined. After evaporation, the crude product
was purified by TLC plate.
4.2.7. 3g. White solid. Mp 97e98 ꢁC. 1H NMR (300 MHz, CDCl3):
d
7.85e7.95 (m, 2H), 7.73e7.85 (m, 2H), 7.60e7.70 (m, 1H),
7.45e7.52 (m,1H), 7.30e7.42 (m,1H), 7.05e7.15 (m,1H), 6.65 (s,1H).
13C NMR (75 MHz, CDCl3)
166.57, 164.02, 160.75, 134.94, 133.01,
130.99, 130.32, 130.21, 126.56, 126.52, 124.16, 118.11, 117.79, 117.32,
d